Wang K, Li X, Guo S, Chen J, Lv Y, Guo Z
Front Oncol. 2025; 15:1545086.
PMID: 39980550
PMC: 11839411.
DOI: 10.3389/fonc.2025.1545086.
Pyrczak-Felczykowska A, Herman-Antosiewicz A
Int J Mol Sci. 2025; 26(3).
PMID: 39941144
PMC: 11818413.
DOI: 10.3390/ijms26031376.
Byadarahalli Ravindranath K, Kandasamy S, Ebaid H, Al-Tamimi J, Talya Narasimhamurthy S, Nagaraja M
ACS Omega. 2025; 10(1):609-618.
PMID: 39829445
PMC: 11740380.
DOI: 10.1021/acsomega.4c07221.
Diaz I, Salido S, Nogueras M, Cobo J
Int J Mol Sci. 2024; 25(17).
PMID: 39273691
PMC: 11396203.
DOI: 10.3390/ijms25179744.
Masci D, Puxeddu M, Silvestri R, La Regina G
Molecules. 2024; 29(9).
PMID: 38731601
PMC: 11085455.
DOI: 10.3390/molecules29092110.
Exploring the Key Amino Acid Residues Surrounding the Active Center of Lactate Dehydrogenase A for the Development of Ideal Inhibitors.
Chen J, Chen C, Zhang Z, Zeng F, Zhang S
Molecules. 2024; 29(9).
PMID: 38731521
PMC: 11085338.
DOI: 10.3390/molecules29092029.
Forward Genetic Screens Identify Mechanisms of Resistance to Small-Molecule Lactate Dehydrogenase Inhibitors.
Frank A, Vandiver F, McFadden D
ACS Chem Biol. 2024; 19(2):471-482.
PMID: 38270591
PMC: 11110909.
DOI: 10.1021/acschembio.3c00663.
Synthesis and LDH Inhibitory Activity of Analogues to Natural Products with 2,8-Dioxabicyclo[3.3.1]nonane Scaffold.
Salido S, Alejo-Armijo A, Altarejos J
Int J Mol Sci. 2023; 24(12).
PMID: 37373073
PMC: 10298284.
DOI: 10.3390/ijms24129925.
Mitochondrial-Encoded Complex I Impairment Induces a Targetable Dependency on Aerobic Fermentation in Hürthle Cell Carcinoma of the Thyroid.
Frank A, Li V, Shelton S, Kim J, Stott G, Neckers L
Cancer Discov. 2023; 13(8):1884-1903.
PMID: 37262072
PMC: 10524862.
DOI: 10.1158/2159-8290.CD-22-0982.
Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer.
Sun N, Kabir M, Lee Y, Xie L, Hu X, Velez J
J Med Chem. 2022; 66(1):596-610.
PMID: 36538511
PMC: 9969998.
DOI: 10.1021/acs.jmedchem.2c01505.
Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications.
Ardestani M, Khorsandi Z, Keshavarzipour F, Iravani S, Sadeghi-Aliabadi H, Varma R
Pharmaceutics. 2022; 14(10).
PMID: 36297655
PMC: 9610671.
DOI: 10.3390/pharmaceutics14102220.
Real-Time Cellular Thermal Shift Assay to Monitor Target Engagement.
Sanchez T, Ronzetti M, Owens A, Antony M, Voss T, Wallgren E
ACS Chem Biol. 2022; 17(9):2471-2482.
PMID: 36049119
PMC: 9486815.
DOI: 10.1021/acschembio.2c00334.
Targeting mitochondrial metabolism for precision medicine in cancer.
Sainero-Alcolado L, Liano-Pons J, Ruiz-Perez M, Arsenian-Henriksson M
Cell Death Differ. 2022; 29(7):1304-1317.
PMID: 35831624
PMC: 9287557.
DOI: 10.1038/s41418-022-01022-y.
Noncoding RNAs in the Glycolysis of Ovarian Cancer.
Zhang C, Liu N
Front Pharmacol. 2022; 13:855488.
PMID: 35431949
PMC: 9005897.
DOI: 10.3389/fphar.2022.855488.
Targeting oncometabolism to maximize immunotherapy in malignant brain tumors.
Bernstock J, Kang K, Klinger N, Olsen H, Gary S, Totsch S
Oncogene. 2022; 41(19):2663-2671.
PMID: 35430605
PMC: 9081266.
DOI: 10.1038/s41388-022-02312-y.
Targeting cancer metabolism in the era of precision oncology.
Stine Z, Schug Z, Salvino J, Dang C
Nat Rev Drug Discov. 2021; 21(2):141-162.
PMID: 34862480
PMC: 8641543.
DOI: 10.1038/s41573-021-00339-6.
A novel series of pyrazole derivatives toward biological applications: experimental and conceptual DFT characterization.
Ortiz P, Castillo-Rodriguez J, Tapia J, Zarate X, Vallejos G, Roa V
Mol Divers. 2021; 26(5):2443-2457.
PMID: 34724138
DOI: 10.1007/s11030-021-10342-z.
CAR T-Cells Depend on the Coupling of NADH Oxidation with ATP Production.
Garcia-Canaveras J, Heo D, Trefely S, Leferovich J, Xu C, Philipson B
Cells. 2021; 10(9).
PMID: 34571983
PMC: 8472053.
DOI: 10.3390/cells10092334.
The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect.
Woodford M, Baker-Williams A, Sager R, Backe S, Blanden A, Hashmi F
Nat Struct Mol Biol. 2021; 28(8):662-670.
PMID: 34381247
PMC: 9278990.
DOI: 10.1038/s41594-021-00633-2.
Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria.
Ding J, Gumpena R, Boily M, Caron A, Chong O, Cox J
ACS Med Chem Lett. 2021; 12(7):1116-1123.
PMID: 34267881
PMC: 8274068.
DOI: 10.1021/acsmedchemlett.1c00196.